Association between Exonic SNPs of TLR5 and Benign Prostate Hyperplasia in Korean Population

다국어 초록 (Multilingual Abstract)

Benign prostatic hyperplasia (BPH) is prevalent in aging male, and it is increasing in Korean male. Factors affecting BPH development include family history. Toll-like receptor (TLR) 5 is a major part of innate immune, and it may contribute to the immunologic responses linked to the BPH pathophysiology. To investigate the genetic effect of the TLR5 polymorphisms on the development and clinical features of BPH, three missense single nucleotide polymorphisms (SNPs) of TLR5 (rs5744168, rs5744174, rs2072493) were tested in 219 BPH and 211 control subjects. The SNPs were genotyped and statistically analysed in multiple logistic regression analysis. rs5744174 was significantly associated with BPH in genotype analysis (codominant2, OR=9.60, p=0.005; recessive, OR=9.15, p=0.001; and log-additive, OR=1.56, p=0.018). rs2072493 was significantly associated with BPH (codominant1, OR=0.65, p=0.042; dominant, OR=0.63, p=0.022; log-additive, OR=0.69, p=0.018; and allele frequencies, OR=0.70, p=0.02). In conclusion, we suggest that TLR5 polymorphisms may be associated with BPH, and that rs5744174 and rs2072493 may be associated with the development of BPH. This study has some limitation, therefore further studies with larger sample size and other populations will be needed to verify our results. (Korean J Str Res 2013;21:331∼337)

국문 초록 (Abstract)

양성 전립선 비대증(BPH)은 가족력이 있는 경우가 많으며 이로부터 유전적 성질이 발병에 관여할 수 있음을 추측된다. Toll-like receptor (TLR) 5는 자연면역 체계의 한 주축이며, 이 유전자에 의한 면역반응은 BPH의 발병에 연관될수 있다. 본 연구에서는 TLR5 유전자의 단일염기다형성(single nucleotide polymorphisms, SNPs)들과 한국인에서의 BPH 와의 상관관계를 연구하였다. 총 3개의 SNP을 선정하였고, 219명의 BPH그룹과 211명의 비 환자 그룹에서 유전형을분석하였다. 실험 결과, 두 개의 missense SNP (rs5744174, rs2072493)이 BPH발병과 유의성을 보였다. 이상의 결과로, TLR5 유전자는 한국인 비만과 유전적 연관이 있을 것으로 생각되며, 이에 대한 추가적인 큰 집단에 대한 연구가이뤄질 필요성이 있을 것으로 생각된다.

참고문헌 (Reference)

1 Stark JR, "Toll-like receptor signaling pathway variants and prostate cancer mortality" 18 : 1859-1863, 2009

2 Hawn TR, "Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women" 4 : e5990-, 2009

3 Wu JF, "Toll-like receptor and hepatitis B virus clearance in chronic infected patients: a long-term prospective cohort study in Taiwan" 206 : 662-668, 2012

4 Leimgruber C, "Testosterone abrogates TLR4 activation in prostate smooth muscle cells contributing to the preservation of a differentiated phenotype" 228 : 1551-1560, 2013

5 Carvalho FA, "TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage" 4 : 102-111, 2011

6 Khasriya R, "Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms" 51 : 2054-2062, 2013

7 Sole X, "SNPStats: a web tool for the analysis of association studies" 22 : 1928-1929, 2006

8 Abu-Maziad A, "Role of polymorphic variants as genetic modulators of infection in neonatal sepsis" 68 : 323-329, 2010

9 McLaren ID, "Role of interleukins, IGF and stem cells in BPH" 82 : 237-243, 2011

10 Yeon Won Park, "Relationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men" 대한남성과학회 30 (30): 183-188, 2012

11 Zhang F, "Polymorphisms in toll-like receptors 2, 4 and 5 are associated with Legionella pneumophila infection" 41 : 941-948, 2013

12 Kim SJ, "Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice" 23 : 113-122, 2012

13 Vijay-Kumar M, "Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5" 328 : 228-231, 2010

14 Lorenz J, "Legionella pneumophila- induced IkappaBzeta-dependent expression of interleukin-6 in lung epithelium" 37 : 648-657, 2011

15 Kopp A, "Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes" 17 : 648-656, 2009

16 Feng RN, "Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial" 56 : 985-994, 2013

17 Zeng HM, "Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population" 20 : 2594-2602, 2011

18 Coenen MJ, "Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome" 5 : e14326-, 2010

19 Qi J, "Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population" 73 : 1182-1190, 2013

20 Povel CM, "Genetic variants and the metabolic syndrome: a systematic review" 12 : 952-967, 2011

21 Card JW, "Gender differences in murine airway responsiveness and lipopolysaccharide-induced inflammation" 177 : 621-630, 2006

22 Moyad MA, "Educating patients about lifestyle modifications for prostate health" 121 : S34-S42, 2008

23 Tewari R, "Diet, obesity, and prostate health: are we missing the link?" 33 : 763-776, 2012

24 Piccinini AM, "DAMPening inflammation by modulating TLR signalling" pii672395-, 2010

25 Cunha C, "DAMP signaling in fungal infections and diseases" 3 : 286-, 2012

26 Siami P, "Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design" 28 : 770-779, 2007

27 Kaplan SA, "Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater" 175 : 217-220, 2006

28 Pisetsky D, "Cell death in the pathogenesis of immunemediated diseases: the role of HMGB1 and DAMP-PAMP complexes" 141 : w13256-, 2011

29 Wang S, "Body mass index and risk of BPH: a meta-analysis" 15 : 265-272, 2012

30 Cohen PG, "Benign prostatic hypertrophy" 41 : 269-, 2009

31 Dhiman N, "Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results" 26 : 1731-1736, 2008

32 정원석, "Association of Toll-Like Receptor 5 Gene Polymorphism with Susceptibility to Ossification of the Posterior Longitudinal Ligament of the Spine in Korean Population" 대한신경외과학회 49 (49): 8-12, 2011

33 조아랑, "Assessment between Dopamine Receptor D2 (DRD2) Polymorphisms and Schizophrenia in Korean Population" 대한정신약물학회 10 (10): 88-93, 2012

34 Vignozzi L, "Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells" 214 : 31-43, 2012

35 Lai JJ, "Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice" 181 : 1504-1512, 2012

36 Quintar AA, "Androgen depletion augments antibacterial prostate host defences in rats" 35 : 845-859, 2012

37 Hawn TR, "A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus" 102 : 10593-10597, 2005

38 Al-Daghri NM, "A nonsense polymorphism (R392X) in TLR5 protects from obesity but predisposes to diabetes" 190 : 3716-3720, 2013

39 Sheridan J, "A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn's disease and influences responses to bacterial flagellin" 8 : e61326-, 2013